Omega-3 Fatty Acids Tied to Better Cardiovascular Outcomes
Cardiovascular risk reduction more prominent with EPA monotherapy versus EPA + DHA therapy
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Cardiovascular risk reduction more prominent with EPA monotherapy versus EPA + DHA therapy
Only registered members have full access to PracticeUpdate content.